ClinVar Miner

Submissions for variant NM_000543.5(SMPD1):c.1529C>T (p.Ser510Phe)

gnomAD frequency: 0.00001  dbSNP: rs200652683
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000664533 SCV000788511 uncertain significance Niemann-Pick disease, type A 2017-01-06 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000731478 SCV000859302 uncertain significance not provided 2018-01-31 criteria provided, single submitter clinical testing
Invitae RCV001085567 SCV001118349 benign Niemann-Pick disease, type B; Niemann-Pick disease, type A 2024-01-25 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000664533 SCV001265041 likely benign Niemann-Pick disease, type A 2017-04-28 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Revvity Omics, Revvity RCV000731478 SCV003822013 uncertain significance not provided 2021-03-23 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003488785 SCV004242005 likely benign not specified 2023-12-08 criteria provided, single submitter clinical testing Variant summary: SMPD1 c.1529C>T (p.Ser510Phe) results in a non-conservative amino acid change located in the Sphingomyelin phosphodiesterase, C-terminal domain (IPR045473) of the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0008 in 251428 control chromosomes, predominantly at a frequency of 0.0064 within the South Asian subpopulation in the gnomAD database, including 4 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in SMPD1 causing Niemann-Pick Disease phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.1529C>T has been reported in the literature in individuals affected with Niemann-Pick Disease (Ranganath_2016, Deshpande_2021). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34273913, 27338287). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified this variant as pathogenic (n=1), uncertain significance (n=3), likely benign (n=2) and benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign.
PreventionGenetics, part of Exact Sciences RCV003945695 SCV004761962 likely benign SMPD1-related condition 2023-12-08 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Natera, Inc. RCV001271474 SCV001452642 likely benign Sphingomyelin/cholesterol lipidosis 2020-04-14 no assertion criteria provided clinical testing
Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS RCV000664533 SCV001738435 pathogenic Niemann-Pick disease, type A 2021-04-25 flagged submission research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.